Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies

Simple item page
dc.contributor.authorBertran-Recasens, Bernat
dc.contributor.authorFigueras-Aguirre, Georgina
dc.contributor.authorRoyo de Mingo, I.
dc.contributor.authorRubio Pérez, Miguel Angel
dc.date.accessioned2022-06-27T06:28:08Z
dc.date.available2022-06-27T06:28:08Z
dc.date.issued2021
dc.format.mimetypeapplication/pdf
dc.identifier.citationBertran Recasens B, Figueras-Aguirre G, Royo De Mingo I, Rubio MÁ. Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies. Neurologia (Engl Ed). 2021 Nov-Dec;36(9):739-42. DOI: 10.1016/j.nrleng.2021.02.006
dc.identifier.doihttp://dx.doi.org/10.1016/j.nrleng.2021.02.006
dc.identifier.issn2173-5808
dc.identifier.urihttp://hdl.handle.net/10230/53589
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofNeurologia (Engl Ed). 2021 Nov-Dec;36(9):739-42
dc.rights© 2021 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Neurología. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleLong-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies
dc.title.alternativeEficacia a largo plazo del rituximab en la neuropatía crónica atáxica con anticuerpos antigangliósidos
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Bertran_neu_long.pdf
Size:
312.49 KB
Format:
Adobe Portable Document Format
Download

Collections

License

Rights